We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+23.93%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$86.5M
AUM Growth
+$6.47M
Cap. Flow
-$1.87M
Cap. Flow %
-2.16%
Top 10 Hldgs %
33.2%
Holding
120
New
33
Increased
16
Reduced
36
Closed
30

Top Buys

Rank Stock Value
1
SYK icon
Stryker
SYK
+$2.09M
2
AGN
Allergan plc
AGN
+$1.67M
3
WCG
Wellcare Health Plans, Inc.
WCG
+$1.52M
4
PFE icon
Pfizer
PFE
+$1.42M
5
UNH icon
UnitedHealth
UNH
+$1.12M

Top Sells

Rank Stock Value
1
ALLK
Allakos
ALLK
+$4.3M
2
UBX
Unity Biotechnology
UBX
+$3.43M
3
NTGN
Neon Therapeutics, Inc. Common Stock
NTGN
+$2.48M
4
BLK icon
Blackrock
BLK
+$1.71M
5
GDDY icon
GoDaddy
GDDY
+$1.69M

Sector Composition

Rank Sector Weight
1 Healthcare 46.46%
2 Technology 17.92%
3 Communication Services 6.41%
4 Consumer Discretionary 5.03%
5 Financials 1.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCRX icon
76
Pacira BioSciences
PCRX
$997M
$121K 0.14%
3,173
-2,978
-48% -$116K
GRTS
77
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$116K 0.13%
8,749
-4,202
-32% -$56.1K
CHRS icon
78
Coherus Oncology
CHRS
$196M
$111K 0.13%
+8,114
New +$108K
MRTX
79
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$96K 0.11%
+1,309
New +$89K
EQ icon
80
Equillium
EQ
$133M
$55K 0.06%
6,926
-953
-12% -$7.85K
APTX
81
DELISTED
Aptinyx Inc. Common Stock
APTX
$55K 0.06%
13,614
-45,226
-77% -$328K
ARAY icon
82
Accuray
ARAY
$34M
$48K 0.06%
10,037
-12,387
-55% -$56.4K
UBX
83
DELISTED
Unity Biotechnology
UBX
$48K 0.06%
596
-30,277
-98% -$3.43M
SNNA
84
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$31K 0.04%
13,247
-2,036
-13% -$5.52K
ABT icon
85
Abbott
ABT
$187B
– –
-22,118
Closed -$1.6M
ALLK
86
DELISTED
Allakos
ALLK
– –
-88,079
Closed -$4.3M
ALLO icon
87
Allogene Therapeutics
ALLO
$694M
– –
-5,007
Closed -$135K
ANAB icon
88
AnaptysBio
ANAB
$1.68B
– –
-6,731
Closed -$429K
ARGX icon
89
argenx
ARGX
$54.1B
– –
-1,148
Closed -$110K
ASND icon
90
Ascendis Pharma A/S
ASND
$16.8B
– –
-271
Closed -$17K
BLK icon
91
Blackrock
BLK
$176B
– –
-4,358
Closed -$1.71M
CI icon
92
CALL
Cigna
CI
$74.6B
– –
-10,700
Closed -$2.03M
CI icon
93
Cigna
CI
$74.6B
– –
-3,918
Closed -$744K
CME icon
94
CME Group
CME
$94.8B
– –
-5,728
Closed -$1.08M
DOCU
95
DocuSign
DOCU
$11.5B
– –
-518
Closed -$21K
DVA icon
96
DaVita
DVA
$11.7B
– –
-12,180
Closed -$627K
ESTC icon
97
Elastic
ESTC
$7.81B
– –
-1,911
Closed -$137K
GDOT icon
98
Green Dot
GDOT
$745M
– –
-3,335
Closed -$265K
KURA icon
99
Kura Oncology
KURA
$850M
– –
-10,072
Closed -$141K
NOW icon
100
ServiceNow
NOW
$129B
– –
-7,055
Closed -$251K
1 2 3
4
5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q1 2019 Portfolio in Review

As of Q1 2019, Partner Investment Management held 120 positions worth $86.5M, up 8.1% from $80.1M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Partner Investment Management's Q1 2019 filing shows 33 new, 16 increased, 36 reduced and 30 closed positions. Its largest new stake was Stryker: 11,607 shares worth $2.29M. The largest sale was Allakos, an estimated $4.3M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, down from 54% a quarter earlier, followed by Technology and Communication Services.

  • Partner Investment Management's largest Q1 2019 buy was Stryker: 11,607 shares worth $2.29M.
  • Partner Investment Management added most to Pfizer in Q1 2019, an estimated $1.42M increase.
  • Partner Investment Management's biggest Q1 2019 reduction was Unity Biotechnology, cutting an estimated $3.43M.
  • Partner Investment Management fully exited Allakos in Q1 2019, selling an estimated $4.3M.
  • Partner Investment Management's ten largest holdings make up 33% of its $86.5M portfolio in Q1 2019.
  • Partner Investment Management opened 33 new positions and closed 30 in Q1 2019.
  • Partner Investment Management's portfolio value rose 8.1% quarter-over-quarter to $86.5M.

Based on Partner Investment Management's 13F filing for Q1 2019, filed 15 May 2019.